Patents Assigned to Voltarra Pharmaceuticals, Inc.
  • CO-ADMINISTRATION OF STEROIDS AND ZOLEDRONIC ACID TO PREVENT AND TREAT OSTEOARTHRITIS
    Publication number: 20150031649
    Abstract: A combination therapy for treating osteoarthritis is disclosed. The combination therapy includes the co-administration of a steroid and Zoledronic Acid. The coadministration of a steroid decreases the production of cytokines, and, therefore, decreases the pro-inflammatory effects of Zoledronic Acid. The co-administration of Zoledronic Acid with steroids treats osteoarthritis, and helps to prevent the onset of osteoarthritis in patients at risk for osteoarthritis.
    Type: Application
    Filed: October 14, 2014
    Publication date: January 29, 2015
    Applicant: Voltarra Pharmaceuticals, Inc.
    Inventor: Ketan Desai
  • Co-administration of steroids and zoledronic acid to prevent and treat osteoarthritis
    Patent number: 8859530
    Abstract: A combination therapy for treating osteoarthritis is disclosed. The combination therapy includes the co-administration of a steroid and Zoledronic Acid. The coadministration of a steroid decreases the production of cytokines, and, therefore, decreases the pro-inflammatory effects of Zoledronic Acid. The co-administration of Zoledronic Acid with steroids treats osteoarthritis, and helps to prevent the onset of osteoarthritis in patients at risk for osteoarthritis.
    Type: Grant
    Filed: March 10, 2014
    Date of Patent: October 14, 2014
    Assignee: Voltarra Pharmaceuticals, Inc.
    Inventor: Ketan Desai